- Home
- ICCC vs DRIO Comparison
ICCC vs DRIO Comparison
Compare ICCC & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- DRIO
- Stock Information
- Founded
- ICCC 1982
- DRIO 2011
- Country
- ICCC United States
- DRIO United States
- Employees
- ICCC N/A
- DRIO N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- ICCC Health Care
- DRIO Health Care
- Exchange
- ICCC Nasdaq
- DRIO Nasdaq
- Market Cap
- ICCC 28.0M
- DRIO 25.1M
- IPO Year
- ICCC 1987
- DRIO N/A
- Fundamental
- Price
- ICCC $4.71
- DRIO $0.70
- Analyst Decision
- ICCC
- DRIO Strong Buy
- Analyst Count
- ICCC 0
- DRIO 1
- Target Price
- ICCC N/A
- DRIO $4.00
- AVG Volume (30 Days)
- ICCC 22.4K
- DRIO 168.1K
- Earning Date
- ICCC 11-13-2024
- DRIO 11-07-2024
- Dividend Yield
- ICCC N/A
- DRIO N/A
- EPS Growth
- ICCC N/A
- DRIO N/A
- EPS
- ICCC N/A
- DRIO N/A
- Revenue
- ICCC $23,838,001.00
- DRIO $23,052,000.00
- Revenue This Year
- ICCC N/A
- DRIO $34.56
- Revenue Next Year
- ICCC N/A
- DRIO $39.35
- P/E Ratio
- ICCC N/A
- DRIO N/A
- Revenue Growth
- ICCC 46.37
- DRIO N/A
- 52 Week Low
- ICCC $3.34
- DRIO $0.65
- 52 Week High
- ICCC $5.82
- DRIO $2.60
- Technical
- Relative Strength Index (RSI)
- ICCC 56.95
- DRIO 44.03
- Support Level
- ICCC $4.38
- DRIO $0.65
- Resistance Level
- ICCC $5.23
- DRIO $0.83
- Average True Range (ATR)
- ICCC 0.47
- DRIO 0.07
- MACD
- ICCC -0.04
- DRIO 0.01
- Stochastic Oscillator
- ICCC 22.92
- DRIO 26.39
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.